Case Reports

doi: 10.25005/2074-0581-2019-21-4-683-688
PERSISTENT UTERINE ARTERY VASOSPASM DURING UTERINE FIBROIDS EMBOLIZATION FOR LEIOMYOMA

F.R. RAKHIMOV1, A.K. BARATOV2, G.T. RASULOVA3

1Department of Surgical Diseases № 2, Avicenna Tajik State Medical University, Dushanbe, Republic of Tajikistan
2Republican Scientific Center for Cardiovascular Surgery, Dushanbe, Republic of Tajikistan
3Tajik Scientific Research Institute of Obstetrics, Gynecology, and Perinatology, Dushanbe, Republic of Tajikistan

Uterine artery embolization (UAE) has been widely used for a number of years as an alternative mini-invasive method of treatment of symptomatic uterine fibroids. The technical aspects of the UFE are described in sufficient detail in various guidelines, recommendations and scientific articles. Along with low trauma and other benefits, UAE, like any other treatment, can be accompanied by some intra- and postinterventional complications. One of the intraoperative complications is uterine artery spasm. In most cases the spasm is eliminated medically and is considered to be a temporary and reverse phenomenon. Persistent spasm of the uterine artery can really prevent the adequate embolization of perifibroid arteries and subsequently cause ineffective treatment. The article provides a case of persistent spasm of the uterine artery at the final stage of its embolization for uterine leiomyoma. A set of intraoperative measures to eliminate this complication is described, which, in the end, allowed to properly complete the intervention.

Keywords: Uterine fibroids, uterine artery embolization, complications, spasm of the uterine artery.

Download file:


References
  1. Wang M, Kohi MP. The rationale, design, and methods of a randomized, controlled trial to evaluate the efficacy of single-dose dexamethasone in reducing post-embolization syndrome in patients undergoing uterine artery embolization. Contemp Clin Trials Commun. 2018;12:85-9. Available from: https:// doi.org/10.1016/j.conctc.2018.09.006.
  2. Laughlin-Tommaso SK, Weaver AL, Vaughan LE, Jacoby V, Stewart EA. Long term outcomes in a randomized controlled trial of uterine artery embolization and MR-guided focused ultrasound: the FIRSTT Study. Fertility and Sterility. 2017;108(3):e26. Available from: https://doi.org/10.1016/j.fertnstert.2017.07.093.
  3. Yadavali R, Ananthakrishnan G, Sim M, Monaghan K, McNaught G, Hamoodi I, et al. Randomised trial of two embolic agents for uterine artery embolisation for fibroids: Gelfoam versus Embospheres (RAGE trial). CVIR Endovasc. 2019;2(4). Available from: https://doi.org/10.1186/s42155-018-0044-y.
  4. Martin J, Bhanot K, Athreya S. Complications and reinterventions in uterine artery embolization for symptomatic uterine fibroids: a literature review and meta analysis. Cardiovasc Intervent Radiol. 2013;36:395-402. Available from: https://doi.org/10.1007/s00270-012-0505-y.
  5. Karlsen K, Hrobjartsson A, Korsholm M, Mogensen O, Humaidan P, Ravn P. Fertility after uterine artery embolization of fibroids: a systematic review. Arch Gynecol Obstet. 2018;297(1):13-25. Available from: https://doi. org/10.1007/s00404-017-4566-7.
  6. Toor SS, Jaberi A, Macdonald DB, McInnes MDF, Schweitzer ME, Rasuli P. Complication rates and effectiveness of uterine artery embolization in the treatment of symptomatic leiomyomas: a systematic review and meta-analysis. Am J Roentgenol. 2012;199(5):1153-63. Available from: https://doi. org/10.2214/AJR.11.8362.
  7. de Bruijn AM, Ankum WM, Reekers JA, Birnie E, van der Kooij SM, Volkers NA, et al. Uterine artery embolization vs hysterectomy in the treatment of symptomatic uterine fibroids: 10-year outcomes from the randomized EMMY trial. Am J Obstet Gynecol. 2016;215(6):745.e1-745.e12. Available from: https:// doi.org/10.1016/j.ajog.2016.06.051.
  8. Fonseca MCM, Castro R, Machado M, Conte T, Girao MJBC. Uterine artery embolization and surgical methods for the treatment of symptomatic uterine leiomyomas: a systemic review and meta-analysis followed by indirect treatment comparison. Clin Ther. 2017;39(7):1438-55.e2. Available from: https:// doi.org/10.1016/j.clinthera.2017.05.346.
  9. Grishin II, Roshchina VA, Kauseva OI, Dobrokhotova YuE. Embolizatsiya matochnykh arteriy v lechenii miomy matki: aktual’nyy podkhod v sovremennykh realiyakh [Embolization of the uterine arteries in treatment of uterine myoma: the actual approach in current realities]. RMZh. Mat’ i ditya. 2018;1(2):169-72.
  10. Kapranov SA, Breusenko VG, Dobrokhotova YuE, Bobrov BYu, Krasnova IA, Kovalenko IB. Embolizatsiya matochnykh arteriy v lechenii miomy matki. V: Bokeriya LA, Alekyan BG. (red.) Rukovodstvo po endovasculyarnoy khirurgii serdtsa i sosudov. T. 1 [Textbook of endovascular surgery for cardiovascular diseases. Vol. 1]. Moscow, RF: NTSSSKH im. A.N. Bakuleva RAMN; 2008. p. 542-97.
  11. Lawson A, Cluver C, Olarogun J, Legge D, Bening S, Dyer S. Uterine artery embolisation for uterine leiomyomas. S Afr J OG. 2014;20(1):18-21. Available from: https://doi.org/10.7196/SAJOG.798.
  12. Klyucharov IV, Khusnutdinova DR, Ampilova EA, Antropova EYu, Glinkin VV. Vliyanie embolizatsii matochnykh arteriy na menstrual’nuyu i reproduktivnuyu funktsii (otdalyonnye rezul’taty i kratkiy obzor literatury) [Influence of embolization of uterine arteries on menstrual and reproductive functions (remote results and brief literature review)]. Prakticheskaya meditsina. 2018;16(7):45-50.
  13. Tskhay VB. Gladkaya VS, Brekhova IS, Bryukhovets SM, Domrachyova MYa, Grebennikova EK, i dr. Sluchay rozhdeniya gigantskogo miomatoznogo uzla posle provedeniya embolizatsii matochnykh arteriy [Case of a giant myoma node birth after uterine arteries embolization]. Mat’ i ditya v Kuzbasse. 2019;2:30-4.
  14. Dobrokhotova YuE, Grishin II, Ibragimova DM, Roshchina VA, Kauseva OI, Sotnikova TN, i dr. Neozhidannyy iskhod embolizatsii matochnykh arteriy (klinicheskoe nablyudenie) [Unexpected outcome of uterine artery embolization (Clinical observation)]. RMZh. Meditsinskoe obozrenie. 2018;10:26-8.
  15. Voogt MJ, Arntz MJ, Lohle PN, Mali WP, Lampmann LE. Uterine fibroid embolisation for symptomatic uterine fibroids: a survey of clinical practice in Europe. Cardiovasc Intervent Radiol. 2011;34(4):765-73. Available from: https://doi.org/10.1007/s00270-010-9978-8.
  16. Denison GL, Van Ha T, Keblinskas D. Treatment of uterine artery vasospasm with transdermal nitroglycerin ointment during uterine artery embolization. Cardiovasc Intervent Radiol. 2005;28(5):670-2. Available from: https://doi. org/10.1007/s00270-004-0293-0.
  17. Wang L, Horiuchi I, Mikami Y, Takagi K, Okochi T, Hamamoto K, et al. Use of intra-arterial nitroglycerin during uterine artery embolization for severe postpartum hemorrhage with uterine artery vasospasm. Taiwan J Obstet Gynecol. 2015:54(2):187-90. Available from: https://doi.org/10.1016/j. tjog.2014.05.006.
  18. Soeda S, Hiraiwa T, Takata M, Kamo N, Sekino H, Nomura S, et al. Unique learning system for uterine artery embolization for symptomatic myoma and adenomyosis for obstetrician-gynecologists in cooperation with interventional radiologists: evaluation of UAE from the point of view of gynecologists who perform UAE. JMIG. 2018;25(1):84-92. Available from: https://doi. org/10.1016/j.jmig.2017.08.008.

Authors' information:


Rakhimov Farshed Rustamovich
Postgraduate Student, Department of Surgical Diseases № 2, Avicenna Tajik State Medical University
ORCID ID: 0000-0001-7418-1383
E-mail: frrahimov@mail.ru

Baratov Alisher Kendzhaevich
Candidate of Medical Sciences, Associate Professor, Endovascular Surgeon, Republican Scientific Center for Cardiovascular Surgery
Researcher ID: AAE-6818-2019
Scopus ID: 8249648700
ORCID ID: 0000-0002-8072-5751
Author ID: 268956
SPIN: 6576-1680
E-mail: alishbar@rambler.ru

Rasulova Gulnora Tairdzhanovna
Candidate of Medical Sciences, Associate Professor, Head of the Department of Pregnancy Pathology № 2, Tajik Scientific Research Institute of Obstetrics, Gynecology, and Perinatology
ORCID ID: 0000-0002-5527-5699
E-mail: g_rasulova@list.ru

Information about support in the form of grants, equipment, medications

The authors did not receive financial support from manufacturers of medicines and medical equipment

Conflicts of interest: No conflict

Address for correspondence:


Baratov Alisher Kendzhaevich
Candidate of Medical Sciences, Associate Professor, Endovascular Surgeon, Republican Scientific Center for Cardiovascular Surgery

734003, Republic of Tajikistan, Dushanbe, Sanoi str., 33

Tel.: +992 (907) 978815

E-mail: alishbar@rambler.ru